L-Carnitine-supplementation in advanced pancreatic cancer (CARPAN) - a randomized multicentre trial

BACKGROUND: Cachexia, a >10% loss of body-weight, is one factor determining the poor prognosis of pancreatic cancer. Deficiency of L-Carnitine has been proposed to cause cancer cachexia. FINDINGS: We screened 152 and enrolled 72 patients suffering from advanced pancreatic cancer in a prospective,...

Descripción completa

Detalles Bibliográficos
Autores principales: Kraft, Matthias, Kraft, Kathleen, Gärtner, Simone, Mayerle, Julia, Simon, Peter, Weber, Eckhard, Schütte, Kerstin, Stieler, Jens, Koula-Jenik, Heide, Holzhauer, Peter, Gröber, Uwe, Engel, Georg, Müller, Cornelia, Feng, You-Shan, Aghdassi, Ali, Nitsche, Claudia, Malfertheiner, Peter, Patrzyk, Maciej, Kohlmann, Thomas, Lerch, Markus M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Short Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3439338/
https://www.ncbi.nlm.nih.gov/pubmed/22824168
http://dx.doi.org/10.1186/1475-2891-11-52

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3439338/
https://www.ncbi.nlm.nih.gov/pubmed/22824168
http://dx.doi.org/10.1186/1475-2891-11-52

Ejemplares similares